logo
#

Latest news with #Fountain

El Mansour Development Partners with Vesta to Launch 'Fountain' – A Landmark Hotel-Style Residential Project in Mokattam
El Mansour Development Partners with Vesta to Launch 'Fountain' – A Landmark Hotel-Style Residential Project in Mokattam

Economic Key

time14-07-2025

  • Business
  • Economic Key

El Mansour Development Partners with Vesta to Launch 'Fountain' – A Landmark Hotel-Style Residential Project in Mokattam

El Mansour Development has announced the signing of a strategic partnership agreement with Vesta to manage its new project, 'Fountain', the first fully serviced luxury apartment complex with a hotel-inspired concept in the Mokattam area. This strategic partnership aims to present a unique model of upscale living that meets the highest international standards. Mr. Amgad Mansour, CEO of El Mansour Development, stated that this successful partnership brings together the essential elements of success, as both companies possess strong investment advantages. El Mansour is known for its promising expertise and solid track record, while Vesta is a global company specialized in managing holiday homes and hotel-style units, with extensive experience in delivering high-quality hospitality services — ensuring an exceptional residential experience for Fountain residents. He added: 'We believe that true luxury lies in the details, and our partnership with Vesta reflects our vision of offering an exceptional residential experience that combines world-class hotel services with the privacy of luxury apartments. Fountain is not just a place to live — it's a lifestyle.' He further explained that 'Fountain' boasts a prime location in the heart of the upscale Mokattam district, near Al Nafoura Square, offering residents stunning views and easy access to key services and facilities. The project features fully furnished luxury apartments with elegant interior design, complemented by integrated hotel-style services, including 24/7 concierge and guest support, smart security systems, daily housekeeping, and a luxurious lobby. Dr. Ahmed Abd El Rasoul, Chief Commercial Officer at El Mansour Development , pointed out that the project offers ready-to-move-in apartments with super-luxury finishing and complete furnishing, saving clients time and effort. The strategic cooperation between El Mansour's real estate development expertise and Vesta's operational excellence guarantees a fully integrated project that is set to become a landmark in hotel-inspired residential projects in Mokattam. He added: 'Fountain introduces a new concept of luxury living in Mokattam, blending the comfort of residential apartments with the world-class services of high-end hotels. It features smart home systems, 24/7 security, and upscale amenities that offer residents a lifestyle centered around quality and sophistication.' تم نسخ الرابط

Skeletal remains found in Michigan field 28 years ago finally ID'd thanks to advanced DNA testing
Skeletal remains found in Michigan field 28 years ago finally ID'd thanks to advanced DNA testing

Yahoo

time01-07-2025

  • Yahoo

Skeletal remains found in Michigan field 28 years ago finally ID'd thanks to advanced DNA testing

The Brief Skeletal remains found in Plymouth in 1997 have been identified thanks to advanced DNA testing. DNA extracted from the bones led to a relative of Benjamin Fountain, who authorities believe died of a head injury. If alive today, Fountain would be 99. PLYMOUTH TOWNSHIP, Mich. (FOX 2) - Almost 30 years after a man's remains were found wrapped in a carpet in Plymouth Township, a murder victim has been laid to rest. DNA testing decades later identified the skeletal remains as Benjamin Harrison Fountain, who would be 99 today. The backstory According to Othram, a forensics company that assisted with the identification, the bones were found in a field off Haggerty Road in Plymouth in May 1997 by a person who was surveying the land to purchase it. Police believed that the remains had been there for years before they were discovered. Investigators were able to determine that the remains were of a man who appeared to have been around 5 feet, 8 inches tall. Shorts found with the remains led investigators to believe he may have been slim. His death was ruled a homicide due to a suspected head injury, and a .357 slug was found with the skeleton. Investigators performed testing on the slug and the clothing found with the skeleton, and also tracked down the origin of a gold class ring found with the remains, but were unsuccessful in identifying who it was. Traditional DNA testing was conducted in 2015 and the results were entered into CODIS, but like other methods of ID'ing the victim, didn't yield any matches. Dig deeper In 2022, the Plymouth Township Police Department teamed with Othram to conduct advanced DNA testing. DNA was extracted from the bones, and Forensic-Grade Genome Sequencing was performed at Othram's Texas lab. Through this, it was discovered that the ancestry of the unknown person was African. By using the DNA profile, Othram's forensic genetic genealogy team developed new leads about possible family members and provided them to police. Police were then able to contact a potential relative and use their DNA to determine Fountain's identity. Who he was Fountain, who was born in Virginia on May 6, 1926, also lived in West Virginia before landing in Detroit. He served in World War II after being drafted. His remains, which had been at the Wayne County Medical Examiner's Office since they were found, were finally laid to rest in May, when he was buried at Our Lady of Hope Cemetery in Brownstown. What we don't know It is unknown who killed Fountain or how he ended up dead in a field. An investigation into his death is ongoing. The Source Othram provided details for this story.

Skeleton in rolled-up carpet in Michigan is ID'd 28 years later, officials say
Skeleton in rolled-up carpet in Michigan is ID'd 28 years later, officials say

Miami Herald

time01-07-2025

  • Miami Herald

Skeleton in rolled-up carpet in Michigan is ID'd 28 years later, officials say

A man looking to buy a property in a Detroit suburb in 1997 was surveying it when he unrolled a piece of carpet to reveal a disturbing find. Clothes, jewelry and skeletal remains spilled out of the piece of carpet in a field on the Plymouth Township property 28 years ago, but officials say the remains had been there for years, according to a June 25 news release from DNASolves. After years of investigation and DNA testing, the remains were identified as Benjamin Harrison Fountain, officials said. Fountain was born in 1926 and would have been in his 70s if he was found alive in 1997, according to investigators. He was born in Virginia and was drafted to serve in World War II, according to DNASolves. He also lived in West Virginia and Detroit. An initial investigation determined he died of a head injury, and his death was ruled a homicide, officials said. No suspects or persons of interest in the man's death were disclosed by authorities. Investigators knew little about the man when he was found but determined he was an adult man with a slim body, according to DNASolves. During the decades-long investigation, officials tested the clothing found with him and tried to determine the origin of the class ring found in the carpet, but still, none of the leads led to his identification. DNA testing started in 2015, but no match to his profile was made, officials said. His DNA was later sent to the Othram lab in Texas where a DNA profile was created and new leads into his identity were found, according to investigators. A potential relative was identified, officials said, and the relative's DNA sample ultimately identified Fountain. Fountain was buried May 16, with his name on his grave, in Brownstown Township, according to officials. Plymouth Township is about a 30-mile drive west from Detroit.

Cleanup on Aisle Med Spa
Cleanup on Aisle Med Spa

Medscape

time01-07-2025

  • Health
  • Medscape

Cleanup on Aisle Med Spa

A few years ago, Denver internist Samuel Fountain, MD, suspected a patient's stroke was linked to a treatment they had received at a local med spa: compounded hormone therapy in the form of long-acting pellets implanted under the skin. These products — delivered via creams, gels, pellets, and more and not approved by US drug regulators — are often marketed as safer or more natural alternatives to standard hormone therapy and are frequently administered at med spas. After contacting the clinic and reviewing notes from the med spa, Fountain grew concerned about the establishment's prescribing and monitoring practices. He's not alone. Nora Lansen, MD, a primary care physician (PCP) and chief medical officer at Elektra Health — a telemedicine site specializing in menopause care — regularly encounters patients experiencing side effects from 'hormone therapy gone wrong.' More than 10,000 med spas perform millions of treatments annually, but they operate in a regulatory gray zone, often outside the oversight required in traditional medical settings. And despite the availability of safe, FDA-approved hormone therapies for menopause, an estimated 2.5 million US women use compounded hormone therapy each year — often at med spas. 'Because these places exist in an unregulated state, they can put patients at risk of practices that aren't necessarily in their best interest,' Fountain said. A 2021 study in Menopause found postmenopausal women using compounded hormone therapy in the form of pellets were significantly more likely to experience adverse effects — including abnormal uterine bleeding and hysterectomy — than those using FDA-approved therapies. The website Reddit is full of threads with women and men asking questions about them, and people reporting they're everything from 'life-changing' to a horror story. The growing popularity of med spas combined with persistent gaps in menopause education among clinicians reveals not only risks to patient safety but also a fractured healthcare system where middle-aged women too often struggle to find appropriate care. Risky Business 'None of these compounding products have been studied in careful, controlled trials. We don't know how much of the prescribed dose is absorbed or the resulting blood levels,' said Jan Shifren, MD, director of the Midlife Women's Health Center at Massachusetts General Hospital in Boston. Jan Shifren, MD One analysis found that 34% of compounded hormone products failed potency testing compared with just 2% of FDA-approved therapies. Pellets often contain androgens, which, in excess, can cause side effects such as acne, hirsutism, and deepening of the voice. Lansen said one of her patients registered testosterone levels triple the normal range. The only evidence-based indication for testosterone therapy in women is hypoactive sexual desire disorder with no other identifiable cause. 'If you spend half an hour taking a history, there's almost always another cause that should be treated first,' Shifren said. Pellets typically deliver supraphysiologic hormone levels, too, far beyond what's needed for symptom relief. 'Estrogen stimulates the uterine lining, and anyone with a uterus needs adequate progestogen to protect against endometrial overgrowth or cancer,' Shifren said. Yet no data show compounded therapies reliably provide that protection. Shifren said she has treated patients with abnormal bleeding and knows colleagues who have diagnosed cancer potentially linked to compounded hormone therapy. Nor are any long-term data available on the potential for compounded hormone therapy to cause cardiovascular disease or breast cancer, Shifren said. And because pellets aren't easily removed, patients often have to wait months for side effects to resolve. 'I do think there are plenty of prescribers who are using compounded treatments in a safe and mindful way, but it's just not evidence-based, and we have FDA-approved options,' Lansen said. 'Even when side effects aren't an issue, some patients tell me, 'I've spent thousands on this and I can't afford to keep going.'' Why Patients Visit Med Spas Med spas, while not without risks, often fill gaps in the current medical system and can feel more accessible to patients. 'Certain patients don't want to go to the doctor to treat a medical problem; they just want to feel better,' Fountain said. In women's health, especially, where care can sometimes feel 'more additive than necessary,' alternative providers are quick to step in, Lansen said. 'You can have vendors who say, 'Your doctor can't do it, but I can.'' Aggressive marketing reinforces the appeal. 'As primary care physicians, we're not out there advertising that we're better than the clinic down the street, but med spas do that,' Fountain said. Their messages often frame treatments as safer, more natural, and more effective, too, regardless of the evidence. One study found 77% of people who used compounded hormone therapy believed it was safer than conventional hormone therapy despite the lack of FDA approval and standardized safety testing. The long shadow of the Women's Health Initiative has also shaped current patient and provider attitudes as the study's early reports raised alarms about the potential hazards of hormone therapy, leading to decades of confusion and avoidance. 'When I was in medical school and residency, we didn't even really talk about hormone therapy,' Lansen said. 'I would say most practicing clinicians are relatively unaware.' 'Women are turning to these questionable alternatives because they can't find a thoughtful clinician who will provide safe, evidence-based care,' Shifren said. 'So in some ways, we've contributed to the problem.' PCPs' Role in Med Spa Management PCPs have a critical role to play in both educating patients and managing complications related to med spa treatments, including hormone therapy, Lansen said. For women within 10 years of their final menstrual period who are younger than 60 years, FDA-approved hormone therapy is generally considered safe. 'Beyond that, we're still learning,' he said. For patients confused by hormone therapy, Shifren suggested education. ''Bioidentical' is a marketing term, not a medical term,' she said. 'If patients request 'natural hormones' identical to those made by their ovaries before menopause, we should prescribe FDA-approved formulations of estradiol and progesterone, not compounded hormones.' FDA-approved hormone therapies are also typically covered by insurance, an important consideration for patients paying out of pocket at med spas. Shifren also stressed the importance of clinician confidence in managing menopause. 'Women deserve care for their symptoms,' she said. Referrals are essential, especially because menopause training among physicians remains limited, though with growing public interest and awareness, menopause care is gaining traction. The Menopause Society is advancing a menopause training program to reach 25,000 healthcare professionals within the next 3 years, many bills have been put forward to address critical gaps in physicians' training and knowledge, and medical residents have reached a general consensus about the necessity of a standardized menopause curriculum. Lansen also urges more holistic care in menopause, noting that symptoms can be difficult to distinguish from other midlife challenges such as lack of sleep, stress, caretaking, and work. 'The average midlife woman is cooking on all burners.' While treatment can come in the form of a prescription, it also involves optimizing sleep and stress levels, conversation, and simply acknowledging life's stressors. 'We can't just say, 'These pellets are terrible, don't ever use them again,' Shifren said. 'We need to say, 'Compounded hormone therapy and pellets can be dangerous. I strongly advise you not to return to the med spa. Let me refer you to someone with expertise in menopausal hormone therapy, and I'll make sure you get a timely appointment.'' To guide patients toward evidence-based care, The Menopause Society's Menopause Society-Certified Practitioner database is a reliable resource for finding trained clinicians. Shifren also helped develop MenoNotes, a free online resource produced by the organization. Ultimately, Fountain said patients will seek medical treatments outside the traditional medical system, and clinicians must adjust their expectations and counsel patients on the potential hazards. 'I will sometimes say, 'This is not a treatment that the traditional medical system would offer, and that's not because we're trying to withhold some magical cure, it's because we took an oath to do no harm,' he said. So long as standards are upheld, he doesn't take issue with the med spa model. 'I just think they have to be held to the same kind of scrutiny as every other medical provider. That's where the lines get blurred a little bit,' Fountain said. 'Doctors can do bad things, too. What matters is whether providers are acting within their scope, following evidence and guidelines, and doing what's beneficial for the patient and not harming them.' The sources in this story reported having no relevant financial conflicts of interest.

US strikes Iran: How Tom Cruise's Top Gun: Maverick eerily predicted Donald Trump's Operation Midnight Hammer
US strikes Iran: How Tom Cruise's Top Gun: Maverick eerily predicted Donald Trump's Operation Midnight Hammer

Time of India

time22-06-2025

  • Entertainment
  • Time of India

US strikes Iran: How Tom Cruise's Top Gun: Maverick eerily predicted Donald Trump's Operation Midnight Hammer

When Top Gun: Maverick stormed theatres in 2022, it wasn't just a sequel—it was a resurrection. It defied every law of modern franchise gravity. No multiverse. No Marvel. No brooding they-them anti-hero. Just the return of a square-jawed cis-American icon doing exactly what he did 36 years ago—only faster, louder, and with a bigger sonic boom, looking like the folks at Scientology had finally found the Fountain of Youth. What made it work? First, it respected the original. No irony. No winks. No smug Gen Z subtext. Tom Cruise didn't hand over the keys—he repossessed the plane, flew it through a canyon at Mach 1.6, and landed it on an aircraft carrier with his grin cryogenically preserved in confidence. Kenny Loggins was still on standby. The soundtrack still slapped. The opening still had that slow-mo montage of jets and muscle, set to a synth-and-snare build-up so patriotic it practically handed you a Coors Light and called you "sir. " There was shirtless beach football. Beer without guilt. Bros being bros in the golden light of American masculinity. Maverick didn't just bring back a movie—it brought back a memory. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Eat 1 Teaspoon Every Night, See What Happens A Week Later [Video] getfittoday Undo Of the good old days, before drone warfare, before greyzone psyops, before movies needed three disclaimers and a trigger warning. A time when war was sexy, the rules were simple, and the only labels that mattered were 'friendly' and 'bogey on your six.' Second, it was real. Practical stunts. Real G-forces. No Marvel mush or green-screen gibberish. You felt every dive, every roll, every breath in a cockpit that looked more like a coffin. In an age of CGI fatigue, Maverick reminded viewers what cinema used to feel like—sweaty palms and pounding heartbeats, set to the scream of a jet engine. But above all, Top Gun: Maverick gave audiences something even rarer: sincerity. It wasn't cynical. It wasn't ashamed of heroism. It put on aviators, turned up the volume, and said: "Let's go." Top Gun Maverick Beach Scene 4K IMAX And go it did—straight into the heart of America's foreign policy theatre. Because what looked like a nostalgia-fuelled testosterone trip in 2022 now feels like something far more uncanny in 2025. As President Donald Trump orders a massive stealth strike on Iran's Fordow nuclear facility, Maverick doesn't look like a movie anymore. It looks like a propehcy. A daring pre-emptive strike. An underground uranium plant. A ticking clock. A threat not to America, but to unnamed "allies in the region." What once felt like high-octane fantasy is now playing out, almost scene for scene, in the skies above the Middle East. And Tom Cruise? He wasn't just making a sequel. He was filming the trailer for Trump's next war. The Anti-Woke Hit That Soared When Maverick dropped, it didn't just break box-office records—it broke Hollywood's progressive chokehold on patriotism. No identity politics. No postmodern angst. No war guilt disguised as character development. Just raw American adrenaline, jet-fuelled storytelling, and Tom Cruise doing what Tom Cruise does best—defying gravity and cultural trends alike. Even Jon Hamm showed up, having shed the whiskey-soaked aura of Don Draper to play a tight-laced, by-the-book commander who looked like he personally banned pronouns from the base. You could almost smell the Aqua Velva. The cast was tailor-made for culture-war glory. Miles Teller stepped in as Rooster—Goose's mustachioed legacy—looking like he belonged on a recruitment poster for bros who bench for liberty. Monica Barbaro played Phoenix, the token female pilot who neither lectured nor got lectured—just flew like hell and left feminism on mute. Glen Powell's Hangman was Iceman 2.0: arrogant, tanned, and ready to drop a snide remark along with his payload. Jennifer Connelly was there too, ageless and cool, running a bar where no one talks politics. No lectures. No apologies. Just call signs, dogfights, and sweat-drenched montages scored to the sound of American confidence. Reagan Redux: Top Gun Was Always Propaganda Top Gun (1986) Official Trailer - Tom Cruise Movie The 1986 Top Gun wasn't just a movie—it was Cold War propaganda with better hair. The Pentagon handed over carriers, jets, and script suggestions. Hollywood returned the favour by air-dropping a generation of recruits into Navy flight school. It was recruitment wrapped in romance and set to guitar riffs. Maverick followed the same flight path. The military offered full support. The Navy looked like gods. But this time, there was a twist: the enemy was unnamed. No Soviet MiGs. No al-Qaeda. Just a faceless rogue nation with a uranium facility in the mountains. The target? An underground enrichment site. The mission? Destroy it before it becomes operational. The threat? Not to America—but to our unnamed "allies in the region." Nobody said Iran. Nobody said Israel. And yet everybody knew. That narrative sleight of hand—so brazen in its vagueness—would soon feel less like creative license and more like strategic foreshadowing. Scene for Scene: Trump's Iran Strike Mirrors the Film In June 2025, President Trump—new term, same instincts—ordered a real-world operation that bore eerie resemblance to Maverick. Seven B-2 bombers took off from the US under the cloak of midnight. The mission: Operation Midnight Hammer. The target: Iran's Fordow uranium enrichment facility, buried in the mountains near Qom. A site designed to withstand everything short of Armageddon. A site built for this very moment. In Maverick, the enemy is never named, but the target is clear: a uranium plant in a GPS-jammed valley, surrounded by surface-to-air missiles and fifth-gen fighters. In real life, Fordow sits in a mountainous fortress, shielded by SAM batteries, jamming tech, and hardened bunkers. In the film: three weeks become ten days become go-time. In reality: intel warned that Iran's enrichment programme was just days from a critical threshold. And in both cases, the justification was identical: not America-first, but ally-defence. In Maverick, it's the vague protection of "our friends in the region." In 2025, Trump didn't even bother with euphemism—Israel was the subtext and subtext became text. It wasn't a shot-for-shot remake. But it was close enough to make even Cruise raise an eyebrow behind his aviators. Whose War Is It Anyway? What made Maverick eerie in hindsight was how little it bothered to justify the mission. No American hostages. No nukes pointed at New York. Just an unspoken understanding that someone else's red line was worth flying into. And that's what the Right is now debating. Why should American pilots risk their lives for foreign bunkers? Why should billion-dollar aircraft be dispatched to send messages on behalf of another democracy? Maverick doesn't ask "why." It only asks: "Can it be done?" That question, in 2025, is no longer rhetorical. The Real Finale: A Flag, a Flyby… and a Fade to Black Maverick ends like every great American military fantasy: mission accomplished, uranium plant obliterated, and Tom Cruise strutting across the tarmac with his abs and aircraft intact. The jets land. The music swells. The flag flutters in cinematic slow motion. It could have been lifted straight from the closing scene of Operation Midnight Hammer. But imagine for a second that Maverick didn't make it. That he was shot down in that snowy canyon, dying for a target that never threatened his home, buried in a country he couldn't name, on a mission no one would claim. Would the audience still cheer? Would they even remember who the war was for? This is the question now circling Washington like an unarmed drone—silent, discomfiting, and impossible to shoot down. When the justification for war is wrapped in vagueness, when the enemy is unnamed, and when "defending our allies" becomes the only plotline—how long before audiences, and voters, stop watching the show? After all, wasn't this the very premise Trump once campaigned against? That MAGA would not behave like Bush-era neocons salivating for another war? That America's sons and daughters would no longer be deployed as global hall monitors in faraway deserts? Only last month in Saudi Arabia, Trump, trying to draw a red line between himself and Dubya, declared: 'In the end, the so-called nation builders wrecked far more nations than they built. ' As David Remnick pointed out in a recent piece in New Yorker , Trump once echoed Bannon and Tucker Carlson when he said: 'In recent years, far too many American Presidents have been afflicted with the notion that it's our job to look into the souls of foreign leaders and use U.S. policy to dispense justice for their sins.' Top Gun: Maverick (2022) Dagger Attack Scene And yet, here we are—seven stealth bombers later. A highly classified mission. A decoy formation. A multi-theatre deployment. A strike not to defend American cities, but to send a message on behalf of regional allies. It may have looked like surgical precision from the skies—but on the ground, it's a policy contradiction wrapped in cinematic déjà vu. Even the bill Trump signed to fund the strike—what he called a 'big, beautiful defence package'—flies in the face of MAGA's small-government gospel. This wasn't lean governance. It was big-budget interventionism, scored by swelling violins and paid for with a trillion-dollar cheque. It ignited a backlash from his base—and a very public falling out with Elon Musk, who accused Trump of abandoning fiscal discipline for Pentagon theatrics. Because it didn't start with a movie. It started with a massacre. On October 7, 2023, Hamas fighters paraglided into southern Israel, launching the deadliest attack in the country's history. That single morning shattered illusions across the region. It led to a brutal war in Gaza. It provoked the Houthis to enter the fray. It drew Hezbollah closer to the edge. And it hardened Israel's posture, setting off a chain reaction that eventually led the US to launch Operation Midnight Hammer. From beach football to bunker busters, from afterburners to actual airstrikes—Top Gun began as propaganda. Maverick upgraded it into spectacle. And Trump's Operation Midnight Hammer may be the moment the reel became real. The movie always had the jets. Reality just pressed play. And if that doesn't make you pause—even if you're wearing aviators—just remember: Not even Tom Cruise can outrun a B-2 bomber. Though, to be fair, he'd probably try. On foot. While dangling off a missile. Smiling. As for the true MAGA believers—those who rallied behind promises of no more endless wars and a return to fiscal sanity—they're left asking the same question Maverick once did: Whose mission was this anyway?

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store